10-Q · May 7, 2026
Bruker reported Q1 2026 revenues of $823.4 million, exceeding expectations of $796.6 million, marking a 2.7% increase year-over-year. The company achieved a non-GAAP EPS of $0.31, while GAAP EPS was significantly lower…
BRKR earnings analysis
10-Q · Filed November 5, 2026 · Our reading of the company's report
The latest report
Bruker delivered $874 million of Q3 revenue and $0.56 of adjusted EPS, with BEST revenue up 11.2% and adjusted operating margin reaching 16.3% on cost reductions. However, a $174.5 million goodwill impairment produced a…
Read full summary
Bruker delivered $874 million of Q3 revenue and $0.56 of adjusted EPS, with BEST revenue up 11.2% and adjusted operating margin reaching 16.3% on cost reductions. However, a $174.5 million goodwill impairment produced a $0.81 GAAP diluted loss, while soft BSI performance and a reduction in FY2026 revenue guidance to $3.52-$3.56 billion temper the operating improvement. The filing reported no material changes in market-risk exposure as of September 30, 2026 and effective disclosure controls.
Reported figures
- Earnings per share
- $-0.81
- Segment
- BEST revenue grew 11.2% year over year; exact segment revenue was not disclosed in the provided 10-Q text.
- Segment
- BSI performance was described as soft; exact segment revenue was not disclosed in the provided 10-Q text.
What stood out
-
Revenue grew year over year
Revenue was $874 million, approximately 1.5% above the $861 million reported in 2025 Q3, although it was $8.0 million below the $866.0 million consensus estimate.
-
Cost cuts drove margin expansion
Adjusted operating margin expanded to 16.3%, according to the associated earnings disclosure, reflecting substantial cost-cutting benefits versus the 2025 Q3 operating margin of negative 6.0%.
-
BEST growth offset BSI weakness
BEST revenue increased 11.2% year over year, helping offset soft performance in the BSI segment.
-
EPS outlook held; revenue outlook cut
FY2026 non-GAAP EPS guidance was maintained at $2.10-$2.15, while revenue guidance was reduced to $3.52-$3.56 billion from $3.54-$3.57 billion.
-
Foreign exchange tailwind removed
The company stated that foreign currency is now expected to be neutral for FY2026 versus a prior 0.5% tailwind.
-
Controls remained effective
Management concluded that disclosure controls were effective as of September 30, 2026, and stated that there had been no material changes in internal control over financial reporting during the quarter.
What to watch
-
Goodwill impairment drove GAAP loss
A $174.5 million goodwill impairment contributed to a GAAP diluted loss of $0.81, materially reducing reported earnings despite adjusted EPS of $0.56.
-
Revenue outlook and FX weakened
FY2026 revenue guidance was lowered to $3.52-$3.56 billion from $3.54-$3.57 billion, and foreign currency moved from an expected 0.5% tailwind to neutral.
-
Litigation and regulatory exposure
The company disclosed exposure to lawsuits, claims, governmental investigations, fines and penalties; as of September 30, 2026, it reported no material pending legal proceedings beyond ordinary routine litigation, but stated that outcomes could materially affect financial condition or liquidity.
Management's outlook
The provided 10-Q excerpt does not contain a new quantitative outlook. The associated November 4, 2026 earnings disclosure maintained FY2026 non-GAAP EPS guidance at $2.10-$2.15 and lowered FY2026 revenue guidance to $3.52-$3.56 billion from $3.54-$3.57 billion; expected foreign-currency impact changed from a 0.5% tailwind to neutral.
Earlier filings 1
Smart money in BRKR
Totals from the last full session. Insider and politician figures cover 90 days.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
See every BRKR trade live.
The free pages stop at the last full session. Trader shows every trade as it prints.
Start tracking No card needed.